# EDGAR Filing Document

**Accession Number:** 0001479681
**File Stem:** 0001628280-25-053849
**Filing Date:** 2025-11
**Character Count:** 5237
**Document Hash:** 7e3b53ae85f6a904ddf0a5d4ffed33fb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-053849.hdr.sgml**: 20251124

**ACCESSION NUMBER**: 0001628280-25-053849

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20251124

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251124

**DATE AS OF CHANGE**: 20251124

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Nutex Health, Inc.
- **CENTRAL INDEX KEY:** 0001479681
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 113363609
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41346
- **FILM NUMBER:** 251513871

**BUSINESS ADDRESS:**
- **STREET 1:** 6030 S. RICE AVE.
- **STREET 2:** SUITE C
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77081
- **BUSINESS PHONE:** (713) 660-0557

**MAIL ADDRESS:**
- **STREET 1:** 6030 S. RICE AVE.
- **STREET 2:** SUITE C
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77081

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Clinigence Holdings, Inc.
- **DATE OF NAME CHANGE:** 20191113

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** iGambit, Inc.
- **DATE OF NAME CHANGE:** 20091230

?xml version='1.0' encoding='ASCII'? nutx-20251124

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

Washington, D.C. 20549

**FORM 8-K** 

**CURRENT REPORT** 

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934** 

Date of Report (Date of earliest event reported): **November 24, 2025** 

**NUTEX HEALTH INC.** 

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware**  | **001-41346** | **11-3363609**  |
| (State or Other Jurisdiction <br>of Incorporation) | (Commission File Number) | (I.R.S. Employer <br>Identification No.) |

---

**6030 S. Rice Ave, Suite C, Houston, Texas 77081** 

(Address of principal executive offices) (zip code)

**(713) 660-0557** 

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| **Common Stock, $0.001 par value**  | **NUTX**  | **The NASDAQ Stock Market LLC**  |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 8.01. Other Events.**

Included as Exhibit 23.1 is an auditors' consent to the incorporation by reference into certain previously filed registration statements of their report relating to the consolidated balance sheet of Nutex Health Inc. (the "Company") as of December 31, 2023, the related consolidated statements of operations, changes in equity and cash flows for each of the two years in the period ended December 31, 2023, and the related notes, which report is included in the Company's Form 10-K/A filed on November 18, 2025.

**Item 9.01 Financial Statements and Exhibits**

*(d) <u>Exhibits</u>*

---

| | |
|:---|:---|
| **Exhibit No.** | **Description of Exhibit** |
| 23.1 | <u>[Consent of Marcum LLP](nutexconsentforfilingwithn.htm)</u> |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: November 24, 2025 | **NUTEX HEALTH INC.**  | **NUTEX HEALTH INC.**  |
|  | By: | */s/ Jon C. Bates*  |
|  |  | Jon C. Bates <br>Chief Financial Officer |

---

## Exhibit 23.1

**<u>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT</u>**

We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-267710, 333-273402 and 333-280495) of our report dated March 28, 2024 relating to the financial statements of Nutex Health Inc. appearing in Amendment No. 2 to the Annual Report on Form 10-K/A of Nutex Health Inc. for the year ended December 31, 2024.

/s/ Marcum LLP

Houston, Texas

November 24, 2025

<br>